Q2 2023 13F Holders as of 30 Jun 2023
-
Type / Class
-
Equity / American Depository Shares
-
Shares outstanding
-
1,786,081
-
Total 13F shares
-
284,444
-
Share change
-
+9,655
-
Total reported value
-
$327,598
-
Price per share
-
$1.16
-
Number of holders
-
9
-
Value change
-
+$11,438
-
Number of buys
-
2
-
Number of sells
-
1
Institutional Holders of KAZIA THERAPEUTICS LTD - American Depository Shares (KZIA) as of Q2 2023
As of 30 Jun 2023,
KAZIA THERAPEUTICS LTD - American Depository Shares (KZIA) was held by
9 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
284,444 shares.
The largest 9 holders included
MORGAN STANLEY, ACADIAN ASSET MANAGEMENT LLC, RHUMBLINE ADVISERS, BNP PARIBAS ARBITRAGE, SNC, NewEdge Advisors, LLC, BANK OF AMERICA CORP /DE/, Allworth Financial LP, Steward Partners Investment Advisory, LLC, and AdvisorNet Financial, Inc.
This page lists
9
institutional shareholders reporting positions in this security
for the Q2 2023 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.